NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...

Damian Williams, the United States Attorney for the Southern District of New York; Frank A. Tarentino III, the Special Agent in Charge of the New York Division of the Drug Enforcement Administration (“DEA”); and Darren B. McCormack, the Acting Special Agent in Charge of the New York Field Office of...

ALBUQUERQUE – Three of the eight defendants indicted following a joint enforcement operation last year in Carlsbad, pleaded guilty in federal court to federal drug offenses. Carlos Venegas, Jr., 24, of Carlsbad, pleaded guilty on March 4, 2024, to one count each of conspiracy to distribute 50 grams and more...

POCATELLO – Dr. Gerald Knouf, a family medicine doctor formerly of Pocatello, Idaho, agreed to pay $96,000 to resolve allegations that he wrote unlawful prescriptions, prescribed dangerous combinations of drugs, and billed Medicare and Medicaid for services that were not performed, U.S. Attorney Josh Hurwit announced today. The settlement also...

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...

WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...

ALBANY, NEW YORK – Danielle Simonson, age 52, of Fort Ann, New York, was sentenced today to 70 months in prison for distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. United States Attorney Carla B. Freedman; Special Agent in Charge Frank A. Tarentino...

ALBUQUERQUE – Towanda R. Thorne-James, Special Agent in Charge of the Drug Enforcement Administration's El Paso Division, and Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Kassandra Lee Perales and Jared Michael Moore, two of the 12 defendants arrested during a joint enforcement...

WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...

BROOKLYN, N.Y. - A fifth superseding indictment was filed today in federal court in Brooklyn charging Ismael Zambada Garcia, also known as “El Mayo,” with conspiring to manufacture and distribute a substance, containing N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide (“fentanyl”), a Schedule II controlled substance intending and knowing that such substances would be unlawfully...